Cole J. Beatty , Raul E. Ruiz-Lozano M.D. , Manuel E. Quiroga-Garza M.D. , Victor L. Perez M.D. , James V. Jester PhD , Daniel R. Saban PhD
{"title":"睑板腺功能障碍中非免疫和免疫反应的阴阳关系","authors":"Cole J. Beatty , Raul E. Ruiz-Lozano M.D. , Manuel E. Quiroga-Garza M.D. , Victor L. Perez M.D. , James V. Jester PhD , Daniel R. Saban PhD","doi":"10.1016/j.jtos.2024.01.004","DOIUrl":null,"url":null,"abstract":"<div><p><span>Meibomian gland dysfunction<span> (MGD) is a leading cause of dry eye disease and one of the most common ophthalmic conditions encountered in eye clinics worldwide. These holocrine glands are situated in the eyelid, where they produce specialized lipids, or meibum, needed to lubricate the eye surface and slow tear film evaporation – functions which are critical to preserving high-resolution vision. MGD results in tear instability, rapid tear evaporation, changes in local microflora, and dry eye disease, amongst other pathological entities. While studies identifying the mechanisms of MGD have generally focused on gland obstruction, we now know that age is a major risk factor for MGD that is associated with abnormal cell differentiation and renewal. It is also now appreciated that immune-inflammatory disorders, such as certain autoimmune diseases and </span></span>atopy<span>, may trigger MGD, as demonstrated through a T cell-driven neutrophil response. Here, we independently discuss the underlying roles of gland and immune related factors in MGD, as well as the integration of these two distinct mechanisms into a unified perspective that may aid future studies. From this unique standpoint, we propose a revised model in which glandular dysfunction and immunopathogenic pathways are not primary versus secondary contributors in MGD, but are fluid, interactive, and dynamic, which we likened to the Yin and Yang of MGD.</span></p></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"32 ","pages":"Pages 81-90"},"PeriodicalIF":5.9000,"publicationDate":"2024-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Yin and Yang of non-immune and immune responses in meibomian gland dysfunction\",\"authors\":\"Cole J. Beatty , Raul E. Ruiz-Lozano M.D. , Manuel E. Quiroga-Garza M.D. , Victor L. Perez M.D. , James V. Jester PhD , Daniel R. Saban PhD\",\"doi\":\"10.1016/j.jtos.2024.01.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Meibomian gland dysfunction<span> (MGD) is a leading cause of dry eye disease and one of the most common ophthalmic conditions encountered in eye clinics worldwide. These holocrine glands are situated in the eyelid, where they produce specialized lipids, or meibum, needed to lubricate the eye surface and slow tear film evaporation – functions which are critical to preserving high-resolution vision. MGD results in tear instability, rapid tear evaporation, changes in local microflora, and dry eye disease, amongst other pathological entities. While studies identifying the mechanisms of MGD have generally focused on gland obstruction, we now know that age is a major risk factor for MGD that is associated with abnormal cell differentiation and renewal. It is also now appreciated that immune-inflammatory disorders, such as certain autoimmune diseases and </span></span>atopy<span>, may trigger MGD, as demonstrated through a T cell-driven neutrophil response. Here, we independently discuss the underlying roles of gland and immune related factors in MGD, as well as the integration of these two distinct mechanisms into a unified perspective that may aid future studies. From this unique standpoint, we propose a revised model in which glandular dysfunction and immunopathogenic pathways are not primary versus secondary contributors in MGD, but are fluid, interactive, and dynamic, which we likened to the Yin and Yang of MGD.</span></p></div>\",\"PeriodicalId\":54691,\"journal\":{\"name\":\"Ocular Surface\",\"volume\":\"32 \",\"pages\":\"Pages 81-90\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2024-01-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ocular Surface\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1542012424000132\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Surface","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1542012424000132","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
睑板腺功能障碍(MGD)是导致干眼症的主要原因,也是全球眼科诊所最常见的眼科疾病之一。睑板腺位于眼睑内,分泌专门的脂质或睑板腺脂,用于润滑眼球表面和减缓泪膜蒸发,这些功能对于保持高分辨率视力至关重要。睑板腺肥大症会导致泪液不稳定、泪液快速蒸发、局部微生物菌群变化和干眼症等病理现象。虽然有关泪腺增生症发病机制的研究一般都集中在腺体阻塞方面,但我们现在知道,年龄是导致泪腺增生症的一个主要风险因素,它与细胞分化和更新异常有关。现在人们还认识到,免疫炎症性疾病,如某些自身免疫性疾病和过敏性疾病,可能会通过 T 细胞驱动的中性粒细胞反应诱发 MGD。在此,我们独立讨论了腺体和免疫相关因素在 MGD 中的潜在作用,并将这两种不同的机制整合为一个统一的视角,以帮助未来的研究。从这一独特的角度出发,我们提出了一个修正模型,即腺体功能障碍和免疫致病途径在 MGD 中并不是主要和次要的促成因素,而是更具流动性、互动性和动态性,我们将其比喻为 MGD 的阴阳。
The Yin and Yang of non-immune and immune responses in meibomian gland dysfunction
Meibomian gland dysfunction (MGD) is a leading cause of dry eye disease and one of the most common ophthalmic conditions encountered in eye clinics worldwide. These holocrine glands are situated in the eyelid, where they produce specialized lipids, or meibum, needed to lubricate the eye surface and slow tear film evaporation – functions which are critical to preserving high-resolution vision. MGD results in tear instability, rapid tear evaporation, changes in local microflora, and dry eye disease, amongst other pathological entities. While studies identifying the mechanisms of MGD have generally focused on gland obstruction, we now know that age is a major risk factor for MGD that is associated with abnormal cell differentiation and renewal. It is also now appreciated that immune-inflammatory disorders, such as certain autoimmune diseases and atopy, may trigger MGD, as demonstrated through a T cell-driven neutrophil response. Here, we independently discuss the underlying roles of gland and immune related factors in MGD, as well as the integration of these two distinct mechanisms into a unified perspective that may aid future studies. From this unique standpoint, we propose a revised model in which glandular dysfunction and immunopathogenic pathways are not primary versus secondary contributors in MGD, but are fluid, interactive, and dynamic, which we likened to the Yin and Yang of MGD.
期刊介绍:
The Ocular Surface, a quarterly, a peer-reviewed journal, is an authoritative resource that integrates and interprets major findings in diverse fields related to the ocular surface, including ophthalmology, optometry, genetics, molecular biology, pharmacology, immunology, infectious disease, and epidemiology. Its critical review articles cover the most current knowledge on medical and surgical management of ocular surface pathology, new understandings of ocular surface physiology, the meaning of recent discoveries on how the ocular surface responds to injury and disease, and updates on drug and device development. The journal also publishes select original research reports and articles describing cutting-edge techniques and technology in the field.
Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.
Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center